Related Experiment Video
Updated: Feb 5, 2026

Biology of Microbial Communities - Interview
Published on: May 28, 2007
Impact of microbial Aetiology on mortality in severe community-acquired pneumonia
Jessica Quah1, Boran Jiang2, Poh Choo Tan3
1Department of Respiratory and Critical Care Medicine, Changi General Hospital, SingHealth, 2 Simei Street 3, Postal Code, Singapore, 529889, Singapore. Jessica_Quah@cgh.com.sg.
Background:
The impact of different classes of microbial pathogens on mortality in severe community-acquired pneumonia is not well elucidated. Previous studies have shown significant variation in the incidence of viral, bacterial and mixed infections, with conflicting risk associations for mortality. We aimed to determine the risk association of microbial aetiologies with hospital mortality in severe CAP, utilising a diagnostic strategy incorporating molecular testing. Our primary hypothesis was that respiratory viruses were important causative pathogens in severe CAP and was associated with increased mortality when present with bacterial pathogens in mixed viral-bacterial co-infections.
Methods:
A retrospective cohort study from January 2014 to July 2015 was conducted in a tertiary hospital medical intensive care unit in eastern Singapore, which has a tropical climate. All patients diagnosed with severe community-acquired pneumonia were included.
Results:
A total of 117 patients were in the study. Microbial pathogens were identified in 84 (71.8%) patients. Mixed viral-bacterial co-infections occurred in 18 (15.4%) of patients. Isolated viral infections were present in 32 patients (27.4%); isolated bacterial infections were detected in 34 patients (29.1%). Hospital mortality occurred in 16 (13.7%) patients. The most common bacteria isolated was Streptococcus pneumoniae and the most common virus isolated was Influenza A. Univariate and multivariate logistic regression showed that serum procalcitonin, APACHE II severity score and mixed viral-bacterial infection were associated with increased risk of hospital mortality. Mixed viral-bacterial co-infections were associated with an adjusted odds ratio of 13.99 (95% CI 1.30-151.05, p = 0.03) for hospital mortality.
Conclusions:
Respiratory viruses are common organisms isolated in severe community-acquired pneumonia. Mixed viral-bacterial infections may be associated with an increased risk of mortality.
Insights
Mixed viral-bacterial infections in severe community-acquired pneumonia (CAP) significantly increase mortality risk. Identifying these co-infections is crucial for patient outcomes in severe CAP cases.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Respiratory Medicine
Background:
- Severe community-acquired pneumonia (CAP) etiology and mortality impact remain unclear.
- Previous studies show conflicting data on viral, bacterial, and mixed infections in CAP.
- Molecular diagnostics are increasingly used to identify pathogens in severe CAP.
Purpose of the Study:
- To determine the association between microbial etiologies and hospital mortality in severe CAP.
- To investigate the role of respiratory viruses, particularly in mixed viral-bacterial co-infections.
- To utilize molecular testing for comprehensive pathogen identification.
Main Methods:
- Retrospective cohort study conducted in a tertiary hospital intensive care unit in Singapore.
- Inclusion criteria: patients diagnosed with severe community-acquired pneumonia.
- Data collected from January 2014 to July 2015, incorporating molecular testing.
Main Results:
- Microbial pathogens identified in 71.8% of 117 severe CAP patients.
- Mixed viral-bacterial co-infections found in 15.4% of patients.
- Mixed viral-bacterial co-infections showed a significantly increased adjusted odds ratio of 13.99 for hospital mortality.
Conclusions:
- Respiratory viruses are frequently detected in severe CAP.
- Mixed viral-bacterial co-infections are associated with a substantially higher risk of hospital mortality.
- Early identification of co-infections is vital for managing severe CAP.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
What are Populations and Communities?
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Impact of Groups on Groups
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

